As part of our activities for Eating Disorders Awareness Week, here is the link to my interview with Leslie Citrome, MD, about binge-eating disorder—what it is, how it can be identified, and how it can be treated.
Dr. Citrome is a leading expert on psychopharmacology, an expert on eating disorders, and a member of the Editorial Board for Simple and Practical.
Please share this link widely by email and on social media.
Dr. Citrome’s LinkedIn post about the special issue of Clinical Therapeutics on Eating Disorders that he co-edited can be found HERE.
This interview was recorded on February 26, 2021.
Related Pages
Why it is important for all of us to screen for eating disorders
How to screen for eating disorders
How to evaluate persons who have or may have an eating disorder
Binge-Eating Disorder
Binge-Eating Disorder Screener-7 (BEDS-7)
New medication approved by FDA for Binge-Eating Disorder
Yale Food Addiction Scale
Instruction sheet for the Yale Food Addiction Scale
Should we prescribe medications for weight loss?
Why it is important to treat obesity
Medications for the treatment of obesity: Overview
Melanocortin 4 receptor (MC4R) and weight gain
References
Citrome L. Binge Eating Disorder: A Psychiatrist’s Commentary on Clinical Considerations. Clin Ther. 2021 Jan;43(1):7-16. doi: 10.1016/j.clinthera.2020.10.013. Epub 2020 Dec 9. PMID: 33308878.
Citrome L. Binge eating disorder revisited: what’s new, what’s different, what’s next. CNS Spectr. 2019 Aug;24(S1):4-13. doi: 10.1017/S1092852919001032. Erratum in: CNS Spectr. 2019 Aug;24(S1):82. PMID: 31196238.
Citrome L. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication – what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract. 2015 Apr;69(4):410-21. doi: 10.1111/ijcp.12639. Epub 2015 Mar 6. PMID: 25752762.
Gasior M, Hudson J, Quintero J, Ferreira-Cornwell MC, Radewonuk J, McElroy SL. A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder. J Clin Psychopharmacol. 2017 Jun;37(3):315-322. doi: 10.1097/JCP.0000000000000702. PMID: 28383364; PMCID: PMC5400413.
Jung J, Fugh-Berman A. Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED). J Am Board Fam Med. 2020 Mar-Apr;33(2):240-251. doi: 10.3122/jabfm.2020.02.190129. PMID: 32179607.
Ward K, Citrome L. Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder. Expert Opin Drug Metab Toxicol. 2018 Feb;14(2):229-238. doi: 10.1080/17425255.2018.1420163. Epub 2018 Jan 4. PMID: 29258368.
Copyright © 2021, Simple and Practical Medical Education, LLC. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave a Reply